The physiology of oxygen transport and red cell transfusion

Wylie and Churchill-Davidsons: A Practice of Anesthesia, Seventh Edition

Volumn , Issue , 2003, Pages 167-183

  Rutter, Timothy W ^a   Tremper, Kevin K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79251548524     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (109)

1. Barcroft J. Presidential address on anoxaemia. Lancet 1920; 2: 485-9.
2. Nunn JF. Applied Respiratory Physiology. London: Butterworth, 1987.
3. Cross CE, Packer BS, Altman M, et al. The determination of total body exchangeable oxygen stores. J Clin Invest 1968; 47:2402-10.
4. Finch CA, Lenfant MD. Oxygen transport in man. N Engl J Med 1972; 286 (8): 407-15.
5. DeHaan EJ. Cell respiration. Folia Med Neerl 1970; 13: 90-100.
6. Baue AE, Soyeed MM. Alterations in the functional capacity of mitochondria in hemorrhagic shock. Surgery 1970; 68: 40-7.
7. Alter MJ, Pascell RM, Shih JW, et al. Detection of antibody C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321:1494.
8. Alter MJ, Hadler SL, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 2231.
9. Tremper KK, Barker SJ. Monitoring of oxygen. In: Lake C (ed.). Clinical Monitoring. London: WB Saunders, 1990.
10. Eichorn JM, Cooper JB, Cullen DJ, et al. Standards for patient monitoring during anesthesia at Harvard Medical School. JAMA 1986; 1256: 1017-20.
11. Richards DW. The Circulation in Traumatic Shock in Man. Harvey Lectures 1943-44; 39: 217.
12. Nunn JF, Freeman J. Problems of oxygenation and oxygen transport during hemorrhage. Anaesthesia 1964; 19: 206.
13. Sullivan SF. Oxygen transport. Anesthesiology 1972; 37:140.
14. Bartlett RH. Critical care. In: Greenfield LJ, Mulholland MW, Oldham KT, Zelenock GB (eds). Surgery, Scientific Principles and Practice. Philadelphia: JB Lippincott, 1993: 195-222.
15. Bartlett RH. Critical care and metabolism. Bull Am Coll Surg 1989; 74: 10-15.
16. Cain SM. Acute lung injury. Assessment of tissue oxygenation. Crit Care Clin 1986; 2: 537-50.
17. Wade OC, Bishop JM. Cardiac Output and Regional Blood Flow. Oxford: Blackwell Scientific Publications, 1962.
18. Cain SM. Oxygen transport and consumption. In: Tinker J, Zapel WM (eds). Care of the Critically III Patient, 2nd edn. Berlin: Springer Verlag, 1992: Chapter 5.
19. Barcroft J. Features in the Architecture of Physiological Function. Cambridge: Cambridge University Press, 1938: 71.
20. 2 tensions and cardiac output by rebreathing method. Respir Physiol 1966; 1:258-64.
21. Scheinmann MM, Brown MA, Rapaport E. Critical assessment of use of central venous oxygen saturation as a mirror of mixed venous oxygen in severely ill cardiac patients. Circulation 1969; 40:165-72.
22. Muir AL, Kirby BJ, King AJ, et al. Mixed venous oxygen saturation in relation to cardiac output in myocardial infarctions. Br Med J 1970; 4: 276-8.
23. Norfleet EA, Watson CB. Continuous mixed venous oxygen saturation measurement: a significant advance in hemodynamic monitoring? J Clin Monitoring 1965; 1: 245-58.
24. Birman H, Hag A, Hew E, et al. Continuous monitoring of mixed venous oxygen saturation in hemodynamically unstable patients. Anesthesiology 1984; 86: 753-6.
25. Carron CC, Snyder JV. Hyperdynamic severe intravascular sepsis depends on fluid resuscitation in cynomolgus monkey. Am J Physiol 1982; 243: R131-41.
26. Miller MJ. Tissue oxygenation in clinical medicine: an historical review. Anesth Analg 1982; 61: 527-35.
27. Lee MD, Wright F, Barber R, Stanley L. Central venous oxygen saturation in shock. Anesthesiology 1972; 36:472-8.
28. Zwischenberger JB, Colley RD, Kirsh MM, et al. Does continuous monitoring of mixed venous oxygen saturation accurately reflect oxygen delivery and oxygen consumption following coronary artery bypass grafting Surgical Forum 1986; 37: 66-8.
29. Cilley RE, Polley TZ, Swischenberger JB, et al. Independent measurement of oxygen consumption and oxygen delivery. J Surg Res 1988; 47: 242-7.
30. Nelson LD. Continuous venous oscimetry in surgical patients. Ann Surg 1986; 203: 329-33.
31. Shenaq SA, Casar G, Ott H, Crawford ES. Continuous monitoring of mixed venous oxygen saturation during aortic surgery. Chest 1987; 97: 796-9.
32. Cregory IC. The oxygen and carbon monoxide capacities of foetal and adult blood. J Physiol (Lond) 1974; 236: 625.
33. Von Hufner CG. NeueVersuchezurBestimmungderSauerstoff Capacitah des Blut Forbstoffs. Arch Anat Physiol Abt 1984; 130.
34. Adair GS. The hemoglobin system vs. The oxygen dissociation curve of hemoglobin. J Biol Chem 1925; 63: 529.
35. Gillies IDS. Anaemia and anaesthesia. BrJAnaesth 1974; 46: 589.
36. Perutz MF. Stereochemistry of cooperative efforts in hemoglobin. Nature (London) 1970; 228:726.
37. Woodson RD., Hemoglobin structure and oxygen transport. Principles of Transfusion Medicine. Baltimore: Williams and Wilkins, 1991.
38. Bellingham AJ, Deto JC, Lenfant C. Regulatory mechanisms of oxygen affinity in acidosis and alkalosis.J Clin Invest 1971; 50: 700.
39. Hamasaki N, Asakura T, Minakami S. Effect of oxygen tension of glycolysis in human erythrocytes.; Biochem (Tokyo) 1970; 68:157-61.
40. Rapaport S. The regulation of glycolysis in mammalian erythrocytes. Essays Biochem 1965; 1: 69-103.
41. Guyton AC., Capillary dynamics and exchange of fluid between the blood and interstitial fluid. Textbook of Medical Physiology, 6th edn. Philadelphia: WB Saunders, 1981: 363.
42. Torrance J, Jacobs P, Restrepo A, et al. Intraerythrocytic adaptation to anemia. N Engl J Med 1970; 283:165.
43. Greenwald I. A new type of phosphoric acid compound isolated from blood, with some remarks on the effect of substitution of the rotation of L-glycergic acid. J Biol Chem 1925; 63: 339.
44. Bluesch R, Bluesch RE. The effect of organic phosphates from the human erythrocyte on the allosteric properties of hemoglobin. Biochem Biophys Res Commun 1967; 26:162.
45. Sharpey Schafer EP. Cardiac output in severe anemia. Clin Sci 1944; 5: 125.
46. Murray JF. Anemia and cardiac function. UCLA Forum Med Sci 1970; 10: 309.
47. Bartlett RH, Dechert RE. Oxygen kinetics: pitfalls in clinical research. J Crit Care 1990; 5 (2); 77-80.
48. Cilley RE, Scharenberg AM, Bongiorno PF, et al. Low oxygen delivery produced by anemia, hypoxia and low cardiac output. J Surg Res 1991; 51:425-33.
49. Simmons DH, Alpas AP, Tashkin DP, Coulson A. Hyperlactemia due to arterial hypoxemia or reduced cardiac output or both. J Appl Physiol 1978;45:195-202.
50. Kasnitz P, Druger GL, Yorra F, Simmons DH. Mixed venous oxygen tension and hyperlactemia. JAMA 1976; 236: 570-4.
51. 50) in patients with acute myocardial infarction and shock. Am J Cardiol 1975; 36:148-54.
52. Cohen RD, Simpson R. Lactate metabolism. Anesthesiology 1975; 43: 661-73.
53. Seibert DJ, Ebaugh Jr FG. Assessment of tissue anoxemia in chronic anemia by the arterial lactate pyruvate ratio and excess lactate formation. J Lab Clin Med 1967; 69:177-82.
54. Green NM, Talner NS. Blood lactate pyruvate and lactate pyruvate ratios in congenital heart disease. N Engl J Med 1964; 270:1331-6.
55. Wolf GT, Coter S, Perel A, Manny J. Dependence of oxygen consumption of cardiac output in sepsis. Crit Care Med 1987; 15:198-203.
56. Shibutani K, Kamatsu T, Kubal K, et al. Critical level of oxygen delivery in anesthetized man. Crit Care Med 1983; 11: 640-3.
57. Danek SJ, Lynch JP, Weg JG, Dantzker DR. The dependence of oxygen uptake on oxygen delivery in the adult respiratory distress syndrome. Am Rev Respir Dis 1980; 122: 387-95.
58. Gutierez G, Pohil RJ. Oxygen consumption is linearly related to oxygen supply in critically ill patients.; Crit Care 1986; 1 (1): 45-53.
59. -1. Anesthesiology 2000;92:407-13
60. Leung JM, Weiskopf RB, Feiner J, et al. Electrocardiographic ST Segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology, 2000; 93:1004-1010.
61. Tremper KK, Friedman AE, Levine EM, et al. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N Engl J Med, 1982; 307: 277-83.
62. Gould SA, Rosen AL, Sehgal LR, et al. Fluosol-DA as a red-cell substitute in acute anemia. N Engl J Med, 1986; 314:1653-6.
63. Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993; 21: 860-6.
64. Hogue CW, Goodnough LT, Monk TG. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion Pract 1998; 38: 924-31.
65. Herbert PC, Wells G, Tweeddale M, et al. Does transfusion practice effect mortality in critically ill patients Am J Respir Crit Care Med 1997; 155: 1618-23.
66. Herbert PC, Wells G, Blajchman MA, et al. A multicentered randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340: 409-17.
67. Practice guidelines for blood component therapy. A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84: 732-47.
68. Goodnough LT, BrecherME, KanterMH, AuBuchonJP: Transfusion medicine. First of two parts - blood transfusion. N Engl J Med, 1999; 340 (6): 438-47.
69. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997; 337: 1861-915.
70. Balajachman MA. Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse. Transfusion 1999; 39: 665-70.
71. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion transmitted viral infections. N Engl J Med 1996; 34:1685-90.
72. Remis RS, Delage G, Palmer RWH. Risk of HIV infection from blood transfusion in Montreal. Can Med Assoc J 1997; 157: 375-82.
73. Linden JV, Kaplan HS. Transfusion errors: cause and effects. Transfusion Med 1994; 8:169-83.
74. Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion associated hepatitis C N Engl J Med 1995; 332:1463-6.
75. Williamson LM, Allain JP. Virally inactivated fresh frozen plasma. Vox Song 1995; 69:159-65.
76. Klein HG, Dodd RY, Dzik WH, et al. Current status of solvents/detergent-treated plasma. Transfusion 1998; 38: 102-7.
77. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. Second of two parts - blood conservation. N Engl J Med, 1999; 340 (7): 525-33.
78. Etchason J, Petz L, Keeler E, et al. Cost-effectiveness of preoperative autologous donations. N Engl J Med 1995; 332: 719-24.
79. Birkmeyer JD, Goodnough LT, AuBuchon JP, et al. The cost-effectiveness of preoperative autologous donation for total hip and knee replacement. Transfusion 1993; 33: 544-51.
80. Birkmeyer JD. Cost-effectiveness of preoperative autologous donation in coronary bypass grafting. Ann ThorSurg 1994; 57:161-9.
81. Kanter NH, vanMaanen D, Anders KH, et al. Preoperative autologous blood donations before elective hysterectomy. JAMA 1996; 276: 798-801.
82. Crosby ET, Murphy P, Benoit PR. Routine pre-deposited autologous blood is not warranted before breast reduction surgery. Can J Surg 1995; 38: 309-13.
83. Goodnough LT. Clinical application of recombinant erythropoietin in the perioperative period. Hematol Oncol Clin North Am 1994; 8:1011-20.
84. Goodnough LT, Price TH, Friedman MJ, et al. A phase II trial of recombinant human erythropoietin therapy in non anemic orthopaedic patients, subjected to removal of blood for autologous use: dose response, toxicity and efficacy. Transfusion 1994; 34: 66-71.
85. Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogenic and autologous blood donation: frequency and characterization. Transfusion 1995; 35: 734-7.
86. Stehling L. Autotransfusion and hemodilution. In: Miller RD (ed.). Anesthesia, 3rd edn. New York: Churchill Livingstone, 1990:1501-3.
87. The National Blood Resource Education Program Expert Panel. The use of autologous blood. JAMA 1990; 263: 414-17.
88. Goodnough LT, Grishaber JE, Monk TG, Catalona WJ. Acute preoperative hemodilution in patients undergoing radical prostatectomy: a case study analysis of efficacy. Anesth Analg 1994; 78: 932-7.
89. Feldman JM, Roth JV, Bjoraker DG. Maximum blood savings by acute normovolemic hemodilution. Anesth Analg 1995; 80:108-13.
90. Brecher ME, Rosenfeld M. Mathematical and computer modeling of acute normovolemic hemodilution. Transfusion 1994; 34:176-9.
91. Bryson GL, Laupacis A, Wells GA, et al. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. Anesth Analg 1998; 86: 9-15.
92. Brainard DMD. Amputation of the thigh for disease of the knee joint: transfusion of blood. Chicago Med J 1860; 18:116-17.
93. Huet C, Salmi LR, Fergusen D, et al. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogenic blood transfusion in cardiac and orthopaedic surgery. Anesth Analg 1999; 89: 861-9.
94. Huber TS, McGorray SP, Carlton LC, et al. Intraoperative autologous transfusion during elective infrarenal aortic reconstruction: a decision analysis model. J Vase Surg 1997; 25: 984-94.
95. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does new technology have to be to warrant adoption and utilization: tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992;146:473-81.
96. Thomas MJG. Infected and malignant fields are an absolute contraindication to intraoperative cell salvage: fact or fiction? Transfusion Med 1999;9:269-78.
97. Hansen E, Knuechel R, Altmeppen J, Taeger K. Blood irradiation for intraoperative autotransfusion in cancer surgery: demonstration of efficient elimination of contaminating tumor cells. Transfusion 1999; 39:608-15.
98. Del Rossi AI, Cernaiann AC, Botros S, et al. Prophylactic treatment of post perfusion bleeding using EACA. Chest 1989; 96: 27.
99. Harrow JC, Hlavacek J, Strong MD, et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thor Cardiovasc Surg 1990; 99: 70.
100. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effects of aprotinin on need for blood transfusion after repeat open heart surgery. Lancet 1987; 2:1289.
101. Royston D. High-dose aprotinin therapy: a review of the first five years' experience. J Cardiothor VascAnesth 1992; 6: 76.
102. Wang JS, Lynn CY, Hung WT, Carp RB. Monitoring of heparin induced anticoagulation with kaolin-activated clotting time in cardiac surgical patients treated with aprotinin. Anesthesiology 1992; 77: 1080-4.
103. Salzman EW, Weinstein MJ, Weintraub RM, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med 1986; 314: 1402.
104. Mannucci PM. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72:1449.
105. Kasper SM, Grune F, Walter M, et al. The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1998; 87: 284-91.
106. Gould SA, Moore EE, Hoyt DB, et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 1998; 187:113-20.
107. Lamy ML, Daily EK, Brichant JF, et al. Randomized trial of diaspirin cross linked hemoglobin solutions as an alternative to blood transfusion after cardiac surgery. Anesthesiology 2000; 92: 646-56.
108. Spahn DR, van Brempt R, Theilmeier G, et al. Perflubron emulsion delays blood transfusions in orthopaedic surgery. Anesthesiology 1999; 91:1195-208.
109. Wahr JA, Tremper KK. Blood substitutes. In: Fleisher LA, Prough DS (eds). Problems in Anesthesia. Philadelphia: Lippincott, Williams and Wilkins, 2000; 82-93.